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866-5 Incidence, Predictors, and Effects on Outcome of First 
Episode of Atrial FlbrllleUon in Patients Diagnosed With 
Mltral Valve Prolapse: A Community Study 
Jean-Francois Aviednos. Maurice Enriquez Sarano, Mayo Foundation, Rochester, 
Minnesota. 
Background: Incidence and predictors of atrial fibdllation (Afib) in the course mitral valve 
prolapse (MVP) have never been defined in the community and its consequences on out- 
come have not been analyzed. 
Methods: In a community sample of 777 Olmsted county patients diagnosed with MVP at 
Mayo Clinic between 1989 and 1996, in sinus rythm at diagnosis (mean age=49+_20, 
66% of females, patients with history of hypertension=11%, mean left ventdcular ejection 
fraction (LVEF)=62±7%, mitral regurgitation greater or equal to moderate=16%), we 
defined long-term rates of first episode of Afib. We analyzed its predictors and its inter- 
action with subsequent occurrence of first ischemic neurologic events (INE). Results: 
During mean FU of 5.5+3.0 years, 63 patients experienced at least one episode of Afib. 
Five- and 10-year rates of Afib were 7±1 and 13~2. percent, respectively. Comparison 
with reported rates in the general population of similar age showed almost twofold 
increase in incidence of Afib in MVP patient. By multivariate analysis, variables indepen- 
dently predictive of Afib (hazards ratio, 95% CI) were: age (1.05 [1.04-1.08], p<0.001 ), 
mitral regurgitation (MR) greater or equal to moderate (8.112.4-28.0], p<0.001 ), slight MR 
(3.711.1-12.6], p=0.03), left atdum diameter (1.9[1.1-3.2], p=0.01) and lower LVEF 
(1.0311.01-1.05], p=0.04). Dudng FU, 5- and 1g-year rates of INE were 3t-0.7 and 7+1 
percent respectively. By multivariate analysis, independent predictors of INE were : Afib 
(4.311.9-10.0], p<0.001) and cardiac surgery performed during FU (2.511.1-5.8], p=0.03), 
tested as 2 time dependent vadables, as well as age (1.08 [1.04-1.11], p<0.001) and 
rnitral valve thickening (3.211.4-7.4], p=0.008) Conclusion: In this large community-based 
study, 1) patients with MVP display high rates of Afib 2) Afib during FU is the major deter- 
minant of occurrence of INE 3) MR at diagnosis is a strong predictor of Afib and appears 
as an indirect risk factor for INE, through Afib and need for cardiac surgery. 
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866-6 Percutaneous Catheter-Based Mitrel Valve Repair 
Stephen N. Oestede, Alan M. Gillingv, Chi-Hui Chin, Yan-Qiu Xing, Aldo D. Prado, 
Natese G. Pandian, Masachusetts General Hospital, Boston, Massachusetts, Tufts-New 
England Medical Center, Boston, Massachusetts. 
Background: 
Mitral regurgitation (MR) is common in patients with Congestive Heart Failure(CHF) 
caused by ischemic and dilated cardiomyopathy. The mechanism of MR in these patients 
is incomplete coaptation of the mitral leaflets due to changes in annular and ventricular 
geometry. Surgical correction is achieved by mitral annuloplasty, which currently entails 
substantial risk and requires cardiopulmonary bypass and cardiac arrest. We have evalu- 
ated a cathetar-based percutaneous transvenous method for mitral repair that uses the 
coronary sinus (Ca)as a delivery pathway. 
Methods: 
Ischemic MR was created by temporary occlusion of the circumflex coronary artery in 6 
healthy, anesthetized 35-45 kg sheep. A 7F sheath was placed percutaneously in the 
jugular vein and advanced into the CS. A composite stainless steel/nitinol annuloplasty 
device was then coaxially passed through the sheath and positioned in the CS during 
ischemic MR under echocadiographic and fluoroscopic guidance. The impact on the 
severity of MR was assessed by echocardiography. 
Results: 
Baseline MR was 0-1+. Circumflex occlusions produced 3-4+ MR and this was reduced 
to 0-1+ MR in all animals by positioning the annuloplasty device in the CS. The annulo- 
plasty device caused conformational changes in the mitral annulus that improved leaflet 
coaptation. Systolic mitral annular diameter decreased from 30 +/- 2.1 to 24 +/- 1.7 mm 
(p<O.O01); MR jet area decreased from 6.54 +/-2.2 to 0.4+/- 0.5cm2 (p<O.O01. Continu- 
ous wave Doppler confirmed that the annuloplasty device did not produce mitral steno- 
sis. MR retumed to 3-4+ upon retraction of the device. Delivery of the annuloplasty 
device is straight forward. It can be deployed in less than one minute following placement 
of of the CS sheath. 
Concluslon: 
Percutaneous mitral repair to treat MR caused by ischemic left ventricular dysfunction is 
feasible and easily accomplished. Transvenous catheter-based mitral annuloplasty otters 
a promising and minimally invasive therapeutic approach for patients with heart failure 
and MR caused by left ventricular dysfunction. 
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1203-131 Energy  Dose for Intra-Operative Biphasic-Shock Direct  
Def ibr i l la t ion 
Birgit Schwarz, Andrew Bowdle, Kimble Jett, Peter Mair, Karl H. Lindner, Gabreal S. 
Aldea, Robert Lazzara, Sharon G. O'Grady, Paul W. Schmitt, Robert G. Walker. Willis A. 
Tacker, University of Innsbruck, Innsbruck, Austria, University of Washington School of 
Medicine, Seattle, Washington. 
Background: Biphasic (B) shocks are becoming standard in external defibrillators, but 
no clinical data have been reported comparing them to conventional monophasic (M) 
shocks for defibrillation (D) via internal paddles. This randomized, controlled trial com- 
pared B to M (damped sine) shocks and provided clinical dosage information. 
Methods: Ninety-one patients undergoing cardioplegic bypass surgery were randomized 
to get either BD or MD after aortic clamp removal. Step-up shocks were given (2,5,7,10 
and 20 Joules (J)) using 2-inch dia. paddles until D occurred. Patients not D with a 20J 
shock were D by either a 20J shock of the other waveform, or by a >20J shock (except 
for one patient that required larger paddles). Cumulative success curves for the two 
waveforms were tested for statistical difference. 
Results: Curves for BD and MD in the figure show higher success rates for BD at all 
energies between 2 and 20J (p=0.027). Compared to the M group, the B group required, 
on average, fewer shocks (2.5 vs 3.5:p=0.002), less threshold energy (6.8 J vs 11.0 J: 
p=0.003) and less cumulative energy (12.6 J vs 23.4 J: p=O.002). 
Conclusions: This study demonstrates the superiority of these B shocks over M shocks, 
and guides selection of first shock B energy dosage. For 2" paddles, a first shock of 5 J 
favors lower initial, cumulative and average threshold energies. A first shock of 10 to 20 J 
favors more rapid D and fewer shocks. Or, customary success rates may be maintained 
by selecting a B energy of 1/2 that now used for M shocks. 
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1203-132 A Shor t -Term Ana lys i s  o f  Permanent Pacemaker 
Implantation and Utilization After Cardiac Surgery  
Jo-ann E. Lynch, James B. Kirchhoffer, James R. Cook, Cynthia B. Kardos, Barry J. 
Karas, Laura L. Liucci, John A. Rousou, Joseph E. Flack, III, David W. Deaton, Daniel T. 
Engelman, Richard M. Engelman, Baystate Medical Center, Springfield, Massachusetts. 
Background: Arrhythmias occur in 40-60% of patients after cardiac surgery, but most 
resolve spontaneously. Permanent pacemakers (PPM) may be implanted postoperatively 
for symptomatic sinus node dysfunction (SND) or AV block (AVB). Previous studies have 
yielded conflicting data on the continued utilization of pacing therapy after heart surgery. 
Methods: We evaluated patients undergoing cardiac surgery at one institution from 8/1992 
to 12/2000. Baseline clinical data, type of operation (CABG +/- valve), cardioplegia, and 
reason for PPM (SND vs. AVB) were recorded. Patients were followed at 4-6 weeks after 
implant and pacer activity evaluated from device memory. Data are presented as mean + 
SD or proportions and linear regression was used to identify factors associated with 
increased PPM use. 
Results: Over the study peried, 6251 patients underwent cardiac surgery of which 107 
patients (1.7%) were identified who suffered postoperative arrhythmias resulting in PPM. In 
the PPM patients, coronary artery bypass grafting was performed in 65%, and valve sur- 
gery in 52%. Warm cardioplegia was used for 87% of all operations. SND was the primary 
indication for 63% of PPM implants. The average time to implant was 6 days postopera- 
tively. 
Compared to the surgical population overall, the pacemaker cohort was older (69±12.3 vs 
66_+11.3 years, p<0.01 ), and more likely to have valve surgery (52% vs. 23%, p<0.001 ), but 
were similar with respect to gender, preoperative diabetes mellitus, hypertension and renal 
failure. PPM implantation for AV block was more likely associated with valve surgew 
(OR=4, p<0.01). 
At follow-up, with data available on 46 patients, the average time spent atrial and ventricu- 
lar pacing was 52% and 62%, respectively (p=NS, SND vs AVB). No other clinical or oper- 
ative variables were associated with more frequent PPM use at the follow-up visit. 
Conclusions: Patients who undergo PPM after cardiac surgery, according to current 
guidelines, employ the pacer frequently. Interestingly, patients with SND exercise both 
atrial and ventdcular pacing as frequently as those with an AVB indication. No preoperative 
variables or medications improved the prediction for postoperative pacemaker utilization. 
